Кульчавеня Е.В., Жукова И.И. Внелегочный туберкулез – вопросов больше, чем ответов. Туберкулез и болезни легких. 2017;95(2):59–63. https://doi.org/10.21292/2075-1230-2017-95-2-59-63..
DOI: 10.21292/2075-1230-2017-95-2-59-63

Kulchavenya E., Kholtobin D., Shevchenko S. Challenges in urogenital tuberculosis. World J Urol. 2020;38(1):89–94. https://doi.org/10.1007/s00345-019-02767-x..
DOI: 10.1007/s00345-019-02767-x

Hardy C.C., Keilich S.R., Harrison A.G., Knight B.E., Baker D.S., Smith P.P. The aging bladder phenotype is not the direct consequence of bladder aging. Neurourol Urodyn. 2019;38(8):2121–2129. https://doi.org/10.1002/nau.24149..
DOI: 10.1002/nau.24149

Hardy C.C., Al-Naggar I.M., Kuo C.-L., Kuchel G.A., Smith P.P. Aging changes in bladder hyperpolarization-activated cyclic nucleotide-gated channels are associated with increasing heterogeneity of adrenergic/mucosal influence on detrusor control in the mouse. J Gerontol A Biol Sci Med Sci. 2021;76(7):1153–1160. https://doi.org/10.1093/gerona/glab070..
DOI: 10.1093/gerona/glab070

Кульчавеня Е.В. Инфекции и секс: туберкулез и другие инфекции урогенитального тракта как причина сексуальных дисфункций. М.: ГЭОТАРМедиа; 2015. 168 с.

Bonkat G., Bartoletti R., Bruyère F., Cai T., Geerlings S.E., Koves S. et al. EAU guidelines on urological infections. EAU Guidelines Office, Arnhem, the Netherlands; 2020. 65 p. Available at: https://docs.yandex.ru/docs/view?tm=1655975639&tld=ru&lanq=en&name=7._2020_EAU_10_2021.pdf&text=Bonkat[%]20G.[%]2C[%]20Bartoletti[%]20R.[%]2C[%]20Bruy[%]C3[%]A8re[%]20F.[%]2C[%]20Cai[%]20T.[%]2C[%]20Geerlings[%]20S.E.[%]2C[%]20Koves[%]20S.[%]20et[%]20al.[%]20EAU[%]20guidelines[%]20on[%]20urological[%]20infections.[%]202021&url=https[%]3A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf&lr=213&mime=pdf&l10n=ru&sign=7102115bbd0c744755f27b4effd3d030&keyno=0&nosw=1&serpParams=tm[%]3D1655975639[%]26tld[%]3Dru[%]26lang[%]3Den[%]26name[%]3D7._2020_EAU_10_2021.pdf[%]26text[%]3DBonkat[%]2BG.[%]252C[%]2BBartoletti[%]2BR.[%]252C[%]2BBruy[%]25C3[%]25A8re[%]2BF.[%]252C[%]2BCai[%]2BT.[%]252C[%]2BGeerlings[%]2BS.E.[%]252C[%]2BKoves[%]2BS.[%]2Bet[%]2Bal.[%]2BEAU[%]2Bguidelines[%]2Bon[%]2Burological[%]2Binfections.[%]2B2021[%]26url[%]3Dhttps[%]253A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf[%]26lr[%]3D213[%]26mime[%]3Dpdf[%]26l10n[%]3Dru[%]26sign[%]3D7102115bbd0c744755f27b4effd3d030[%]26keyno[%]3D0[%]26nosw[%]3D1.https://docs.yandex.ru/docs/view?tm=1655975639&tld=ru&lanq=en&name=7._2020_EAU_10_2021.pdf&text=Bonkat[%]20G.[%]2C[%]20Bartoletti[%]20R.[%]2C[%]20Bruy[%]C3[%]A8re[%]20F.[%]2C[%]20Cai[%]20T.[%]2C[%]20Geerlings[%]20S.E.[%]2C[%]20Koves[%]20S.[%]20et[%]20al.[%]20EAU[%]20guidelines[%]20on[%]20urological[%]20infections.[%]202021&url=https[%]3A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf&lr=213&mime=pdf&l10n=ru&sign=7102115bbd0c744755f27b4effd3d030&keyno=0&nosw=1&serpParams=tm[%]3D1655975639[%]26tld[%]3Dru[%]26lang[%]3Den[%]26name[%]3D7._2020_EAU_10_2021.pdf[%]26text[%]3DBonkat[%]2BG.[%]252C[%]2BBartoletti[%]2BR.[%]252C[%]2BBruy[%]25C3[%]25A8re[%]2BF.[%]252C[%]2BCai[%]2BT.[%]252C[%]2BGeerlings[%]2BS.E.[%]252C[%]2BKoves[%]2BS.[%]2Bet[%]2Bal.[%]2BEAU[%]2Bguidelines[%]2Bon[%]2Burological[%]2Binfections.[%]2B2021[%]26url[%]3Dhttps[%]253A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf[%]26lr[%]3D213[%]26mime[%]3Dpdf[%]26l10n[%]3Dru[%]26sign[%]3D7102115bbd0c744755f27b4effd3d030[%]26keyno[%]3D0[%]26nosw[%]3D1

Bonkat G., Bartoletti R., Bruyère F., Cai T., Geerlings S.E., Koves S. et al. EAU guidelines on urological infections. EAU Guidelines Office, Arnhem, the Netherlands; 2020. 65 p. Available at: https://docs.yandex.ru/docs/view?tm=1655975639&tld=ru&lanq=en&name=7._2020_EAU_10_2021.pdf&text=Bonkat[%]20G.[%]2C[%]20Bartoletti[%]20R.[%]2C[%]20Bruy[%]C3[%]A8re[%]20F.[%]2C[%]20Cai[%]20T.[%]2C[%]20Geerlings[%]20S.E.[%]2C[%]20Koves[%]20S.[%]20et[%]20al.[%]20EAU[%]20guidelines[%]20on[%]20urological[%]20infections.[%]202021&url=https[%]3A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf&lr=213&mime=pdf&l10n=ru&sign=7102115bbd0c744755f27b4effd3d030&keyno=0&nosw=1&serpParams=tm[%]3D1655975639[%]26tld[%]3Dru[%]26lang[%]3Den[%]26name[%]3D7._2020_EAU_10_2021.pdf[%]26text[%]3DBonkat[%]2BG.[%]252C[%]2BBartoletti[%]2BR.[%]252C[%]2BBruy[%]25C3[%]25A8re[%]2BF.[%]252C[%]2BCai[%]2BT.[%]252C[%]2BGeerlings[%]2BS.E.[%]252C[%]2BKoves[%]2BS.[%]2Bet[%]2Bal.[%]2BEAU[%]2Bguidelines[%]2Bon[%]2Burological[%]2Binfections.[%]2B2021[%]26url[%]3Dhttps[%]253A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf[%]26lr[%]3D213[%]26mime[%]3Dpdf[%]26l10n[%]3Dru[%]26sign[%]3D7102115bbd0c744755f27b4effd3d030[%]26keyno[%]3D0[%]26nosw[%]3D1.https://docs.yandex.ru/docs/view?tm=1655975639&tld=ru&lanq=en&name=7._2020_EAU_10_2021.pdf&text=Bonkat[%]20G.[%]2C[%]20Bartoletti[%]20R.[%]2C[%]20Bruy[%]C3[%]A8re[%]20F.[%]2C[%]20Cai[%]20T.[%]2C[%]20Geerlings[%]20S.E.[%]2C[%]20Koves[%]20S.[%]20et[%]20al.[%]20EAU[%]20guidelines[%]20on[%]20urological[%]20infections.[%]202021&url=https[%]3A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf&lr=213&mime=pdf&l10n=ru&sign=7102115bbd0c744755f27b4effd3d030&keyno=0&nosw=1&serpParams=tm[%]3D1655975639[%]26tld[%]3Dru[%]26lang[%]3Den[%]26name[%]3D7._2020_EAU_10_2021.pdf[%]26text[%]3DBonkat[%]2BG.[%]252C[%]2BBartoletti[%]2BR.[%]252C[%]2BBruy[%]25C3[%]25A8re[%]2BF.[%]252C[%]2BCai[%]2BT.[%]252C[%]2BGeerlings[%]2BS.E.[%]252C[%]2BKoves[%]2BS.[%]2Bet[%]2Bal.[%]2BEAU[%]2Bguidelines[%]2Bon[%]2Burological[%]2Binfections.[%]2B2021[%]26url[%]3Dhttps[%]253A[%]2F[%]2Fanest.vn.ua[%]2Ffile[%]2F7._2020_EAU_10_2021.pdf[%]26lr[%]3D213[%]26mime[%]3Dpdf[%]26l10n[%]3Dru[%]26sign[%]3D7102115bbd0c744755f27b4effd3d030[%]26keyno[%]3D0[%]26nosw[%]3D1

Кульчавеня Е.В., Брижатюк Е.В., Хомяков В.Т., Бреусов А.А. Частота возникновения цистита в зависимости от вида контрацепции. Урология. 2013;(1):41–43. Режим доступа: https://lib.medvestnik.ru/articles/Chastota-vozniknoveniya-cistita-v-zavisimosti-ot-vida-kontracepcii.html.https://lib.medvestnik.ru/articles/Chastota-vozniknoveniya-cistita-v-zavisimosti-ot-vida-kontracepcii.html

Кульчавеня Е.В., Брижатюк Е.В., Хомяков В.Т., Бреусов А.А. Частота возникновения цистита в зависимости от вида контрацепции. Урология. 2013;(1):41–43. Режим доступа: https://lib.medvestnik.ru/articles/Chastota-vozniknoveniya-cistita-v-zavisimosti-ot-vida-kontracepcii.html.https://lib.medvestnik.ru/articles/Chastota-vozniknoveniya-cistita-v-zavisimosti-ot-vida-kontracepcii.html

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992. https://doi.org/10.1097/GME.0000000000001609..
DOI: 10.1097/GME.0000000000001609

Panay N. Genitourinary syndrome of the menopause – dawn of a new era? Climacteric. 2015;18(Suppl_1):13–17. https://doi.org/10.3109/13697137.2015.1070564..
DOI: 10.3109/13697137.2015.1070564

Kyriakides R., Jones P., Somani B.K. Role of D-Mannose in the prevention of recurrent urinary tract infections: evidence from a systematic review of the literature. Eur Urol Focus. 2021;7(5):1166–1169. https://doi.org/10.1016/j.euf.2020.09.004..
DOI: 10.1016/j.euf.2020.09.004

Scaglione F., Musazzi U.M., Minghetti P. Considerations on D-mannose mechanism of action and consequent classification of marketed healthcare products. Front Pharmacol. 2021;12:636377. https://doi.org/10.3389/fphar.2021.636377..
DOI: 10.3389/fphar.2021.636377

Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. https://doi.org/10.1038/nrurol.2010.190..
DOI: 10.1038/nrurol.2010.190

Eells S.J., Bharadwa K., McKinnell J.A., Miller L.G. Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model. Clin Infect Dis. 2014;58(2):147–160. https://doi.org/10.1093/cid/cit646..
DOI: 10.1093/cid/cit646

Lenger S.M., Bradley M.S., Thomas D.A., Bertolet M.H., Lowder J.L., Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048..
DOI: 10.1016/j.ajog.2020.05.048

Ciani O., Grassi D., Tarricone R. An economic perspective on urinary tract infection: the “costs of resignation”. Clin Drug Investig. 2013;33(4):255–261. https://doi.org/10.1007/s40261-013-0069-x..
DOI: 10.1007/s40261-013-0069-x

Renard J., Ballarini S., Mascarenhas T., Zahran M., Quimper E., Choucair J., Iselin C.E. Recurrent lower urinary tract infections have a detrimental effect on patient quality of life: a prospective, observational study. Infect Dis Ther. 2014;4(1):125–135. https://doi.org/10.1007/s40121-014-0054-6..
DOI: 10.1007/s40121-014-0054-6

Sarshar M., Behzadi P., Ambrosi C., Zagaglia C., Palamara A.T., Scribano D. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics (Basel). 2020;9(7):397. https://doi.org/10.3390/antibiotics9070397..
DOI: 10.3390/antibiotics9070397

Berry R.E., Klumpp D.J., Schaeffer A.J. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun. 2009;77(7):2762–2772. https://doi.org/10.1128/IAI.00323-09..
DOI: 10.1128/IAI.00323-09

Симаненков В.И., Маев И.В., Ткачева О.Н., Алексеенко С.А., Андреев Д.Н., Бордин Д.С. и др. Синдром повышенной эпителиальной проницаемости в клинической практике. мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):2758. https://doi.org/10.15829/1728-8800-2021-2758..
DOI: 10.15829/1728-8800-2021-2758

Thänert R., Reske K.A., Hink T., Wallace M.A., Wang B., Schwartz D.J. et al. Comparative genomics of antibiotic-resistant uropathogens implicates three routes for recurrence of urinary tract infections. Am Soc Microbiol. 2019;10(4):e01977–e019819. https://doi.org/10.1128/mBio.01977-19..
DOI: 10.1128/mBio.01977-19

Loubet P., Ranfaing J., Dinh A., Dunyach-Remy C., Bernard L., Bruyère F. et al. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. 2020;11:1509. https://doi.org/10.3389/fmicb.2020.01509..
DOI: 10.3389/fmicb.2020.01509

Hu X., Shi Y., Zhang P., Miao M., Zhang T., Jiang B. D-Mannose: properties, production, and applications: An overview. Compr Rev Food Sci Food Saf. 2016;15(4):773–785. https://doi.org/10.1111/1541-4337.12211..
DOI: 10.1111/1541-4337.12211

Zhang D., Chia C., Jiao X., Jin W., Kasagi S., Wu R. et al. D-mannose induces regulatory T cells and suppresses immunopathology. Nat Med. 2017;23(9):1036–1045. https://doi.org/10.1038/nm.4375..
DOI: 10.1038/nm.4375

Alton G., Hasilik M., Niehues R., Panneerselvam K., Etchison J.R., Fana F., Freeze H.H. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 1998;8(3):285–295. https://doi.org/10.1093/glycob/8.3.285..
DOI: 10.1093/glycob/8.3.285

Wellens A., Garofalo C., Nguyen H., Van Gerven N., Slättegård R., Hernalsteens J.-P. et al. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS ONE. 2008;3(4):e2040. https://doi.org/10.1371/journal.pone.0002040..
DOI: 10.1371/journal.pone.0002040

Alton G., Kjaergaard S., Etchison J.R., Skovby F., Freeze H.H. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med. 1997;60(2):127–133. https://doi.org/10.1006/bmme.1997.2574..
DOI: 10.1006/bmme.1997.2574

Durán J.M., Cano M., Peral M.J., Ilundáin A.A. D-mannose transport and metabolism in isolated enterocytes. Glycobiology. 2004;14(6):495–500. https://doi.org/10.1093/glycob/cwh059..
DOI: 10.1093/glycob/cwh059

Sharma V., Ichikawa M., Freeze H.H. Mannose metabolism: more than meets the eye. Biochem Biophys Res Commun. 2014;453(2):220–228. https://doi.org/10.1016/j.bbrc.2014.06.021..
DOI: 10.1016/j.bbrc.2014.06.021

Wei Z., Huang L., Cui L., Zhu X. Mannose: Good player and assister in pharmacotherapy. Biomed Pharmacother. 2020;129:110420. https://doi.org/10.1016/j.biopha.2020.110420..
DOI: 10.1016/j.biopha.2020.110420

Sharon N. Carboydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006;1760(4):527–537. https://doi.org/10.1016/j.bbagen.2005.12.008..
DOI: 10.1016/j.bbagen.2005.12.008

Schaeffer A.J., Amundsen S.K., Jones J.M. Effect of carbohydrates on adherence of Escherichica coli to human urinary tract epithelial cells. Infect Immun. 1980;30(2):531–537. https://doi.org/10.1128/iai.30.2.531-537.1980..
DOI: 10.1128/iai.30.2.531-537.1980

Altarac S., Papeš D. Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women. BJU Int. 2014;113(1):9–10. https://doi.org/10.1111/bju.12492..
DOI: 10.1111/bju.12492

Zhou G., Mo W.J., Sebbel P., Min G., Neubert T.A., Glockshuber R. et al. Uroplakin Ia is the urothelial receptor for uropathogenic escherichia coli: evidence from in vitro fimh binding. J Cell Sci. 2001;114(Pt_22):4095–4103. https://doi.org/10.1242/jcs.114.22.4095..
DOI: 10.1242/jcs.114.22.4095

Cusumano C.K., Pinkner J.S., Han Z., Greene S.E., Ford B.A., Crowley J.R. et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med. 2011;3(109):109ra115. https://doi.org/10.1126/scitranslmed.3003021..
DOI: 10.1126/scitranslmed.3003021

Aydin A., Ahmed K., Zaman I., Khan M.S., Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J. 2015;26(6):795–804. https://doi.org/10.1007/s00192-014-2569-5..
DOI: 10.1007/s00192-014-2569-5

Kalas V., Pinkner J.S., Hannan T.J., Hibbing M.E., Dodson K.W. et al. Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci Adv. 2017;3(2):e1601944. https://doi.org/10.1126/sciadv.1601944..
DOI: 10.1126/sciadv.1601944

Sauer M.M., Jakob R.P., Luber T., Canonica F., Navarra G., Ernst B. et al. Binding of the bacterial adhesin fimh to its natural, multivalent high-mannose type glycan targets. J Am Chem Soc. 2019;141(2):936–944. https://doi.org/10.1021/jacs.8b10736..
DOI: 10.1021/jacs.8b10736

Pan Y.T., Xu B., Rice K., Smith S., Jackson R., Elbein A.D. Specificity of the high-mannose recognition site between Enterobacter cloacae pili adhesin and HT-29 cell membranes. Infect Immun. 1997;65(10):4199–4206. https://doi.org/10.1128/iai.65.10.4199-4206.1997..
DOI: 10.1128/iai.65.10.4199-4206.1997

Jones C.H., Pinkner J.S., Roth R., Heuser J., Nicholes A.V., Abraham S.N., Hultgren S.J. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A. 1995;92(6):2081–2085. https://doi.org/10.1073/pnas.92.6.2081..
DOI: 10.1073/pnas.92.6.2081

Poole N.M., Green S.I., Rajan A., Vela L.E., Zeng X.-L., Estes M.K., Maresso A.W. Role for FimH in extraintestinal pathogenic escherichia coli invasion and translocation through the intestinal epithelium. Infect Immun. 2017;85(11):e00581–e00587. https://doi.org/10.1128/IAI.00581-17..
DOI: 10.1128/IAI.00581-17

Mydock-McGrane L.K., Hannan T.J., Janetka J.W. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease. Expert Opin Drug Discov. 2017;12(7):711–731. https://doi.org/10.1080/17460441.2017.1331216..
DOI: 10.1080/17460441.2017.1331216

Ohman L., Magnusson K.E., Stendahl O. Effect of monosaccharides and ethyleneglycol on the interaction between Escherichia coli bacteria and Octyl-Sepharose. Acta Pathol Microbiol Immunol Scand B. 1985;93(2): 133–138. https://doi.org/10.1111/j.1699-0463.1985.tb02864.x..
DOI: 10.1111/j.1699-0463.1985.tb02864.x

Feenstra T., Thøgersen M.S., Wieser E., Peschel A., Ball M.J., Brandes R. et al. Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations. Eur J Clin Microbiol Infect Dis. 2017;36(3):467–478. https://doi.org/10.1007/s10096-016-2820-8..
DOI: 10.1007/s10096-016-2820-8

Ofek I., Goldhar J., Eshdat Y., Sharon N. The importance of mannose specific adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl. 1982;33:61–67. Available at: https://pubmed.ncbi.nlm.nih.gov/6753135/.https://pubmed.ncbi.nlm.nih.gov/6753135/

Ofek I., Goldhar J., Eshdat Y., Sharon N. The importance of mannose specific adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl. 1982;33:61–67. Available at: https://pubmed.ncbi.nlm.nih.gov/6753135/.https://pubmed.ncbi.nlm.nih.gov/6753135/

Schwartz D.J., Kalas V., Pinkner J.S., Chen S.L., Spaulding C.N., Dodson K.W., Hultgren S.J. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc Natl Acad Sci U S A. 2013;110(39):15530–15537. https://doi.org/10.1073/pnas.1315203110..
DOI: 10.1073/pnas.1315203110

Kranjčec B., Papeš D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. https://doi.org/10.1007/s00345-013-1091-6..
DOI: 10.1007/s00345-013-1091-6

Del Popolo G., Nelli F. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch Ital Urol Androl. 2018;90(2):101–103. https://doi.org/10.4081/aiua.2018.2.101..
DOI: 10.4081/aiua.2018.2.101

Pugliese D., Acampora A., Porreca A., Schips L., Cindolo L. Effectiveness of a novel oral combination of D-Mannose, pomegranate extract, prebiotics and probiotics in the treatment of acute cystitis in women. Arch Ital Urol Androl. 2020;92(1):34–38. https://doi.org/10.4081/aiua.2020.1.34..
DOI: 10.4081/aiua.2020.1.34

Phé V., Pakzad M., Haslam C., Gonzales G., Curtis C., Porter B. et al. Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis. Neurourol Urodyn. 2017;36(7):1770–1775. https://doi.org/10.1002/nau.23173..
DOI: 10.1002/nau.23173

Parrino B., Schillaci D., Carnevale I., Giovannetti E., Diana P., Cirrincione G., Cascioferro S. Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem. 2019;161:154–178. https://doi.org/10.1016/j.ejmech.2018.10.036..
DOI: 10.1016/j.ejmech.2018.10.036

Mainini G., Passaro M., Schiattarella A., Franciscis P., Donna M.C.D., Trezza G. Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea, Orthosiphon and Lactobacillus acidophilus. Prz Menopauzalny. 2020;19(3):130–134. https://doi.org/10.5114/pm.2020.99567..
DOI: 10.5114/pm.2020.99567

Domenici L., Monti M., Bracchi C., Giorgini M., Colagiovanni V., Muzii L., Panici P.B. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920–2925. Available at: https://pubmed.ncbi.nlm.nih.gov/27424995/.https://pubmed.ncbi.nlm.nih.gov/27424995/

Domenici L., Monti M., Bracchi C., Giorgini M., Colagiovanni V., Muzii L., Panici P.B. D-mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur Rev Med Pharmacol Sci. 2016;20(13):2920–2925. Available at: https://pubmed.ncbi.nlm.nih.gov/27424995/.https://pubmed.ncbi.nlm.nih.gov/27424995/

Alton G., Hasilik M., Niehues R., Panneerselvam K., Etchison J.R., Fana F., Freeze H.H. Direct manipulation of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 2001;8(3):285–295. https://doi.org/10.1093/glycob/8.3.285..
DOI: 10.1093/glycob/8.3.285

Davis J.A., Freeze H.H. Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse. Biochim Biophys Acta. 2001; 1528(2–3):116–126. https://doi.org/10.1016/s0304-4165(01)00183-0..
DOI: 10.1016/s0304-4165(01)00183-0

Bouckaert J., Berglund J., Schembri M., De Genst E., Cools L., Wuhrer M. et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol. 2005;55(2):441–455. https://doi.org/10.1111/j.1365-2958.2004.04415.x..
DOI: 10.1111/j.1365-2958.2004.04415.x

Lopez A.I., Kumar A., Planas M.R., Li Y., Nguyen T.V., Cai C. Biofunctionalization of silicone polymers using poly (amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization. Bimaterials. 2011;32(19):4336–4346. https://doi.org/10.1016/j.biomaterials.2011.02.056..
DOI: 10.1016/j.biomaterials.2011.02.056

Franssen M., Cook J., Robinson J., Williams N., Glogowska M., Yang Y. et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open. 2021;11(1):e037128. https://doi.org/10.1136/bmjopen-2020-037128..
DOI: 10.1136/bmjopen-2020-037128

Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Эффективность комбинированной антибактериально-пребиотической терапии в сочетании с D-маннозой у женщин с неосложненной инфекцией нижних мочевых путей. Урология. 2019;(6):38–43. https://doi.org/10.18565/urology.2019.6.38-43..
DOI: 10.18565/urology.2019.6.38-43

Кузьмин И.В., Слесаревская М.Н., Аль-Шукри С.Х. Антиадгезивная стратегия неантибактериальной профилатики рецидивирующей инфекции нижних мочевыводящих путей. Урология. 2021;(3):5–12. https://doi.org/10.18565/urology.2021.3:5-12..
DOI: 10.18565/urology.2021.3:5-12

Тетерина Т.А., Ищук М.П., Аполихина И.А. Современные подходы к терапии и профилактике рецидивирующих циститов у беременных с применением D-маннозы: результаты проспективного рандомизированного клинического исследования. Эффективная фармакотерапия. 2021;17(9):6–14. Режим доступа: https://umedp.ru/articles/sovremennye_podkhody_k_terapii_i_profilaktike_retsidiviruyushchikh_tsistitov_u_beremennykh_s_primene.html.https://umedp.ru/articles/sovremennye_podkhody_k_terapii_i_profilaktike_retsidiviruyushchikh_tsistitov_u_beremennykh_s_primene.html

Тетерина Т.А., Ищук М.П., Аполихина И.А. Современные подходы к терапии и профилактике рецидивирующих циститов у беременных с применением D-маннозы: результаты проспективного рандомизированного клинического исследования. Эффективная фармакотерапия. 2021;17(9):6–14. Режим доступа: https://umedp.ru/articles/sovremennye_podkhody_k_terapii_i_profilaktike_retsidiviruyushchikh_tsistitov_u_beremennykh_s_primene.html.https://umedp.ru/articles/sovremennye_podkhody_k_terapii_i_profilaktike_retsidiviruyushchikh_tsistitov_u_beremennykh_s_primene.html